Exelixis, Cereplast gain; drug indexes split

Shares of Exelixis gain ground a day after regulatory filings revealed that two of its top execs made substantial purchases of the biotech company's stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.